HOLMER ALAN F 4
4 · Corbus Pharmaceuticals Holdings, Inc. · Filed Jan 30, 2024
Insider Transaction Report
Form 4
HOLMER ALAN F
Director
Transactions
- Exercise/Conversion
Common Stock
2024-01-26$4.97/sh+629$3,126→ 1,379 total - Exercise/Conversion
Options to purchase common stock
2024-01-26$4.97/sh−629$3,126→ 0 totalExercise: $4.97From: 2014-02-28Exp: 2024-01-29→ Common stock (629 underlying)
Footnotes (1)
- [F1]The annual option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option vested in equal monthly installments over a period of 12 months commencing on February 28, 2014.